Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
30
Number of overlapping holdings
81.1%
% of BHCHX's 40 holdings also in FHLC
8.7%
% of FHLC's 369 holdings also in BHCHX
Overlap by Weight
Sector Drift (BHCHX minus FHLC)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BHCHX |
Weight in FHLC |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY AND COMPANY | 9.3% | 10.2% | 9.3% |
|
UNITEDHEALTH GROUP INCORPORATED | 7.3% | 8.3% | 7.3% |
|
MERCK & CO., INC. | 4.8% | 5.0% | 4.8% |
|
THERMO FISHER SCIENTIFIC INC | 4.7% | 3.6% | 3.6% |
|
INTUITIVE SURGICAL, INC. | 5.8% | 2.5% | 2.5% |
Position Highlights (Non-Overlapping Exposures)
BHCHX Overweight Relative to FHLC
 |
ARGENX SE ADR | 4.1% |
|
BOSTON SCIENTIFIC CORPORATION | 3.6% |
|
BOSTON SCIENTIFIC CORP | 3.6% |
|
INTUITIVE SURGICAL, INC. | 3.3% |
|
INTUITIVE SURGICAL INC | 3.3% |
 |
ICON PLC | 3.2% |
|
VERTEX PHARMACEUTICALS INC | 2.6% |
|
VERTEX PHARMACEUTICALS INCORPORATED | 2.6% |
|
ARCELLX, INC. | 2.6% |
|
THE COOPER COMPANIES, INC. | 2.3% |
BHCHX Underweight Relative to FHLC
|
JOHNSON & JOHNSON | -6.1% |
|
ABBVIE INC | -5.2% |
|
ABBOTT LABORATORIES | -2.9% |
|
AMGEN INC | -2.8% |
|
PFIZER INC | -2.7% |
|
REGENERON PHARMACEUTICALS | -1.8% |
|
MEDTRONIC PLC | -1.6% |
|
BRISTOL-MYERS SQUIBB CO | -1.6% |
|
CIGNA CORPORATION | -1.5% |
|
GILEAD SCIENCES INC | -1.5% |